Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Long-term study of postmenopausal women does not support many preventive therapies
May 02, 2024
Hormone therapy was no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation was no aid for universal fracture prevention.
Social determinants of health linked to TBI incidence in older adults
Jun 06, 2024
Respondents with TBI were more likely to be female and white and have normal cognition, higher education and wealth.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.
Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Antihypertensive meds initiation linked to fractures in nursing home seniors
Apr 23, 2024
Antihypertensive medication initiation also was linked to a higher risk for severe falls requiring hospitalization and emergency department visits.
Self-, partner-reported cognitive decline linked to tau
May 30, 2024
Significant associations were seen between self- and study partner-reported Cognitive Function Index and tau driven by elevated Aβ.
Differences ID’d in tau burden in Down syndrome, Alzheimer’s disease
Apr 25, 2024
Differences in spatial distribution, timing and magnitude of tau burden were seen for two genetic forms of Alzheimer’s disease.